NCT05642247View on ClinicalTrials.gov

Quantify the Value of Transmural Inflammation in the Treatment of Crohn's Disease With Ustekinumab:an Analysis Based on Imaging Science

CompletedOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

January 31, 2023

Conditions

Inflammatory Bowel DiseasesCrohn DiseaseBiologics

Trial Locations (1)

501655

the Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou

All Listed Sponsors

lead

Sixth Affiliated Hospital, Sun Yat-sen University

OTHER